Why is CQA important?
Critical Quality Attributes are the measurable characteristics that determine the identity, potency, safety, purity, and quality of a drug substance or drug product. They are the quantifiable parameters crucial for ensuring the consistency and reproducibility of the drug throughout its lifecycle.
The CQA analyzes all elements of a quality system and assesses its degree of compliance (conformity) to established criteria and standards. Understand the various types of quality audits as well as the steps involved in planning, conducting, and closing out an audit.
CQA – Critical Quality Attributes
The FDA says CQAs apply to any “physical, chemical, biological, or microbiological property or characteristic” that must be within a limit or range to ensure the pharmaceutical product meets the required quality standard.
How to Define CQA? A CQA is a physical, chemical, biological, or microbiological property or characteristic that should be within an appropriate limit, range, or distribution to ensure the desired product quality. CQAs are difficult to measure directly in production.
Definitions. ➢Critical Quality Attributes (CQA) – A physical, chemical, biological, or microbiological. property or characteristic that should be within an. appropriate limit, range, or distribution to ensure.
ICH 6A further defines CQA specifications as the criteria that a drug substance or drug product must meet to be considered acceptable for its intended use. This includes attributes like identity, strength, purity and potency.
Customer Service QA, sometimes referred to as CQA, is a holistic view of quality assurance that represents both the customers' and the organization's perspective by combining customer survey, QA, and call compliance metrics.
CQA authorizes FDA to assess and collect fees from entities that register with FDA as outsourcing facilities. FDA spends fee revenues to hire, support, and maintain personnel for the oversight of these outsourcing facilities.
CQAs are a set of criteria to which a drug product should conform to be considered acceptable for its intended use. These attributes include in-process product identity, as well as potency, purity and safety.
CQA is defined in ICH guidance Q81 as “a physical, chemical, biological or microbiological property or characteristics that should be within an appropriate limit, range, or distribution to ensure the desired product quality.” Typically, CQAs for a given product are defined early in development prospectively based on ...
What is the difference between CPP and CQA in pharma?
A Critical Process Parameter (CPP) is a term used in pharmaceutical production for process variables which have an impact on a critical quality attribute (CQA) and, therefore, should be monitored or controlled to ensure the drug product obtains the desired quality.
Continuous Quality Assurance (CQA) & DevOps.
The quality attributes of a drug product may include identity, assay, content uniformity, degradation products, residual solvents, drug release or dissolution, moisture content, microbial limits, and physical attributes such as color, shape, size, odor, score configuration, and friability.
Quality assurance in the pharmaceutical industry includes: Lab testing to ensure that pharmacopoeial standards are met. Shipment inspections that involve both a visual examination of the product and a review of specifications, including expiration dates.
It involves systematic activities and processes that monitor, evaluate, and improve the quality of deliverables. To cater to the diverse needs of different industries, QA encompasses four distinct types: internal QA, external QA, process QA, and product QA.
The BLS also reports that the median annual wage for software developers, quality assurance analysts, and testers is $109,020 The job outlook is expected to grow 25 percent from 2021 to 2031 [2]. As of May 2021, the median annual salary for quality control inspectors is $38,580 [3].
Quality attribute criticality is primarily based upon severity of harm and does not change as a result of risk management. Process parameter criticality is linked to the parameter's effect on any critical quality attribute.
The FDA conducts three types of inspections: For-cause inspections are triggered at any time when there is reason to believe a facility has serious manufacturing problems or to investigate a specific problem or product complaint that has come to FDA's attention.
Parameters for the process must be maintained in a narrow range to ensure performance consistency and robustness. The key process parameters are those that, when varied within the characterization range, have a significant impact on crystal growth. Definition of the key parameters strongly depends on the growth method.
Potency testing involves comparison of a product's biological activity to that of a reference preparation and cell-based potency assays are central tools used to measure drug efficacy during potency testing. They allow scientists to see how a particular dose of a drug will react in a given biological system.
How is potency determined?
Potency is defined as the concentration of the drug in a compounded preparation. 5 Potency tests are known as quantitative tests and are designed to determine how much of the drug is in the sample. 3 High-performance liquid chromatography (HPLC) is the method typically employed in determining potency.
In general, potency refers to a drug's concentration, while efficacy refers to a drug's ability. A higher potency does not necessarily mean a higher efficacy.
Impact ratios quantify a process parameter's practical effect on a critical quality attribute relative to the critical quality attribute's acceptance limits. Numerator N = the distance between the predicted CQA at the process parameter's high setting and the average CQA at the process parameter's target setting.
Risk assessment, as it is described in ICH Q9, is a systematic method of gathering data to support risk decisions that are made as part of a risk management process. 2. The word “process” has a variety of connotations when referring to pharmaceutical quality.
Product CQAs can be determined based on prior knowledge and the target product profile, and they should always be considered during the formulation and process development. For example, sterility (and in most cases endotoxin content) is by default an essential CQA for all sterile products.
References
- https://www.fda.gov/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066341/
- https://www.fda.gov/about-fda/economics-staff/fda-glance
- https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/pure-food-and-drug-act
- https://www.bu.edu/articles/2023/judge-ruling-abortion-pill-impact-fda-approved-drugs/
- https://www.fda.gov/industry/fda-user-fee-programs/fda-user-fees-explained
- https://www.fda.gov/drugs/development-approval-process-drugs
- https://www.optelgroup.com/en/blog/drug-supply-chain-security-act-dscsa/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907423/
- https://www.azonano.com/article.aspx?ArticleID=6283
- https://www.fda.gov/media/151975/download
- https://finance.yahoo.com/news/top-16-medicine-producing-countries-120134464.html
- https://oig.hhs.gov/oei/reports/oei-03-90-02300.pdf
- https://www.federalregister.gov/agencies/drug-enforcement-administration
- https://en.wikipedia.org/wiki/An_act_to_regulate_the_time_and_manner_of_administering_certain_oaths
- https://www.fda.gov/about-fda/changes-science-law-and-regulatory-authorities/part-i-1906-food-and-drugs-act-and-its-enforcement
- https://www.arlok.com/news/stability-versus-potency-testing
- https://www.cardinalhealth.com/content/dam/corp/web/documents/brochure/CardinalHealth-DrugTracingFAQsCustomers.pdf
- https://pubmed.ncbi.nlm.nih.gov/21698778/
- https://pharmanewsintel.com/news/fundamentals-of-the-pharmaceutical-supply-chain
- https://mitsloan.mit.edu/press/measuring-risks-and-rewards-drug-development-new-research-mit-shows-success-rates-clinical-trials-are-higher-previously-thought
- https://www.svarlifescience.com/services/bioanalytical-services/potency-testing
- https://www.americanpharmaceuticalreview.com/Featured-Articles/359768-Critical-Quality-Attributes-Assessment-and-Testing-Strategy-for-Biotherapeutics-Development/
- https://www.altersis-performance.com/continuous-quality-assurance/
- https://press.princeton.edu/books/paperback/9780691141800/reputation-and-power
- https://www.hamiltoncompany.com/process-analytics/process-analytical-technology/critical-quality-attributes
- https://study.com/learn/lesson/pharmacology-terms-potency-efficacy-affinity.html
- https://www.fda.gov/about-fda/changes-science-law-and-regulatory-authorities/fdas-legal-authority
- https://www.fda.gov/about-fda/fda-organization/fda-organization-charts
- https://www.fda.gov/media/104094/download
- https://www.bio.org/media/press-release/new-study-shows-rate-drug-approvals-lower-previously-reported
- https://www.whitehouse.gov/about-the-white-house/our-government/the-legislative-branch/
- https://www.fiercepharma.com/pharma/from-old-behemoth-lipitor-to-new-king-humira-u-s-best-selling-drugs-over-25-years
- https://pubmed.ncbi.nlm.nih.gov/665689/
- https://www.sciencedirect.com/topics/engineering/key-process-parameter
- https://en.wikipedia.org/wiki/Drug_Quality_and_Security_Act
- https://www.understandinganimalresearch.org.uk/news/why-do-90-of-new-drugs-fail
- https://www.fda.gov/about-fda/fda-history/milestones-us-food-and-drug-law
- https://www.mcguirewoods.com/client-resources/alerts/2013/12/drug-quality-and-security-act/
- https://www.fda.gov/media/164429/download
- https://medium.com/@sajiveva1112000/understanding-the-four-types-of-quality-assurance-for-exceptional-results-bef3168060fc
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911992/
- https://www.wsj.com/us-news/oregon-decriminalized-hard-drugs-it-isnt-working-78ee7476
- https://www.fda.gov/about-fda/changes-science-law-and-regulatory-authorities/fdas-origin
- https://go.drugbank.com/stats
- https://www.fda.gov/drugs/enforcement-activities-fda/unapproved-drugs
- https://pubmed.ncbi.nlm.nih.gov/31793428/
- https://blog.tracktracerx.com/hda-updates-their-q/a-for-the-dscsa
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070262/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866602/
- https://www.qualifyze.com/resources/blog/what-is-the-pharmaceutical-supply-chain/
- https://www.fda.gov/media/116304/download
- https://rarediseases.org/wp-content/uploads/2014/12/NORD-TimeLine.pdf
- https://www.nature.com/articles/s41591-020-01200-w
- https://www.dea.gov/drug-information/csa
- https://www.eurofinsus.com/food-testing/resources/usda-vs-fda-food-labeling/
- https://slcontrols.com/qbd-cqa-cpp-pat-understanding-process-validation-terminology/
- https://clincalc.com/DrugStats/Top300Drugs.aspx
- https://www.fda.gov/media/133830/download
- https://www.fda.gov/media/115824/download
- https://crsreports.congress.gov/product/pdf/R/R44782
- https://www.meps.ahrq.gov/data_files/publications/st245/stat245.pdf
- https://www.nichd.nih.gov/health/topics/pharma/conditioninfo/approval
- https://en.wikipedia.org/wiki/Food_and_Drug_Administration
- https://www.cbo.gov/publication/57126
- https://www.fda.gov/media/148197/download
- https://www.fda.gov/files/about%20fda/published/2017-New-Drug-Therapy-Approvals-Report.pdf
- https://en.wikipedia.org/wiki/Office_of_Criminal_Investigations
- https://constitutioncenter.org/the-constitution/articles/article-i/clauses/752
- https://oig.hhs.gov/oei/reports/oei-09-00-00380.pdf
- https://www.fda.gov/about-fda/fda-basics/when-and-why-was-fda-formed
- https://www.pharmacytimes.com/view/pharmacies-gear-up-for-dscsa-interoperability-go-live-deadline
- https://www.quora.com/Is-the-FDA-constitutional
- https://www.hamiltoncompany.com/process-analytics/process-analytical-technology/critical-process-parameters
- https://www.linkedin.com/pulse/fda-delays-dscsa-drug-supply-chain-security
- https://www.fda.gov/about-fda/fda-basics/fda-fundamentals
- https://www.nature.com/articles/d41573-023-00001-3
- https://www.fda.gov/about-fda/fda-organization
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609997/
- https://www.lilly.com/news/stories/accelerated-approval-get-needed-treatments-patients
- https://phrma.org/Scientific-Innovation/In-The-Pipeline
- https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q8-q9-q10-questions-and-answers-appendix-qas-training-sessions-q8-q9-q10-points-consider
- https://www.ncbi.nlm.nih.gov/books/NBK236093/
- https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/fda-related-laws-regulations-and-guidances
- https://www.fda.gov/drugs/drug-safety-and-availability/dscsa-compliance-policies-establish-1-year-stabilization-period-implementing-electronic-systems
- https://pqri.org/wp-content/uploads/2015/10/01-How-to-identify-CQA-CPP-CMA-Final.pdf
- https://en.wikipedia.org/wiki/History_of_the_Food_and_Drug_Administration
- https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa
- https://www.fda.gov/about-fda/what-we-do
- https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa/fda-announces-proposed-rule-national-standards-licensure-wholesale-drug-distributors-and-third-party
- https://lifesciencesintelligence.com/features/the-top-5-most-expensive-fda-approved-gene-therapies
- https://www.dda.gov.np/content/about-us
- https://landmarkrecovery.com/history-of-us-drug-enforcement/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151195/
- https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa/what-do-i-need-know-about-supply-chain-security-requirements-under-drug-supply-chain-security-act
- https://ncs-conference.org/wp-content/uploads/2022/12/Lamerz-D3-20m-V2-An-update-on-Roche_s-experience-with-the-Impact-Ratio-year-six.pdf
- https://library.weill.cornell.edu/about-us/snake%C2%A0oil%C2%A0-social%C2%A0media-drug-advertising-your-health/food-and-drug-administration-continued
- https://www.fda.gov/media/109482/download
- https://www.fda.gov/about-fda/fda-history-exhibits/80-years-federal-food-drug-and-cosmetic-act
- https://www.upm-inc.com/why-is-pharmaceutical-quality-assurance-important
- https://www.visitthecapitol.gov/exhibitions/congress-and-progressive-era/pure-food-and-drug-act
- https://510kfda.com/pages/fda-510k-costs
- https://blog.tracktracerx.com/will-affected-dscsa
- https://pubmed.ncbi.nlm.nih.gov/34662058/
- https://crstoday.com/articles/2011-oct/a-brief-history-of-the-fda
- https://www.asq.org/cert/resource/pdf/certification/FactSheets/CQA%20Fact%20Sheet.pdf
- https://alirahealth.com/education-hub/critical-quality-attributes-for-drug-products/
- https://www.coursera.org/articles/quality-assurance-vs-quality-control
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293739/
- https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa/pharmacists-utilize-dscsa-requirements-protect-your-patients
- https://www.usp.org/sites/default/files/fda-exhibit/legislation/1938.html
- https://www.sqmgroup.com/resources/library/blog/customer-quality-assurance-cqa
- https://www.law.cornell.edu/wex/commerce_clause
- https://blog.perkinelmer.com/posts/the-four-pillars-of-critical-quality-attributes/
- https://www.ncbi.nlm.nih.gov/books/NBK582130/
- https://www.fda.gov/about-fda/fda-commissioner
- https://www.fda.gov/about-fda/office-policy-legislation-and-international-affairs/office-legislation
- https://www.fda.gov/about-fda/histories-fda-regulated-products/history-drug-regulation
- https://www.fda.gov/federal-state-local-tribal-and-territorial-officials/fda-contacts-regulatory-partners
- https://www.fda.gov/medical-devices/home-use-devices/fdas-role-regulating-medical-devices
- https://scholarship.law.campbell.edu/cgi/viewcontent.cgi?article=1222&context=clr
- https://www.goodrx.com/drugs/medication-basics/what-are-unapproved-drugs
- https://www.supplychaindive.com/news/pharmaceutical-traceability-law-DSCSA-delayed-2024-healthcare-supply-chain/693431/
- https://www.statnews.com/2020/11/03/should-fda-be-independent/
- https://www.fda.gov/about-fda/fda-basics/what-does-fda-regulate
- https://www.fda.gov/regulatory-information/fda-rules-and-regulations
- https://www.usa.gov/agencies/food-and-drug-administration
